News & Blog

International Low-Grade Glioma Patient Registry

Low-grade gliomas (LGG), those classified as Grade II by the World Health Organization, are an understudied group of brain tumors that generally strikes patients in the prime of life. They have a lower average age at diagnosis, but fortunately have a better survival prognosis than high-grade gliomas (those classified as Grades III and IV). While […]

Brain Tumor Research Highlights: November 2016

NOTE: In October, our 2016 NBTS Scientific Summit Recap replaced our typical monthly Brain Tumor Research Highlights. To view that post, click here. To view September’s Brain Tumor Research Highlights, see here. Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding […]

From the CEO’s Desk: The Cancer Moonshot is Ready for Liftoff

On Monday, October 17, 2016, the White House released the final report of theCancer Moonshot Task Force during a special event in Washington, D.C. The report consists of detailed findings and recommendations aimed at accelerating our understanding of cancer and its prevention, early detection, and treatment. As part of this report, the Vice President also unveiled a […]

Share